Journal of Clinical Medicine (Aug 2023)

Hypertensive Heart Failure

  • Filippos Triposkiadis,
  • Pantelis Sarafidis,
  • Alexandros Briasoulis,
  • Dimitrios E. Magouliotis,
  • Thanos Athanasiou,
  • John Skoularigis,
  • Andrew Xanthopoulos

DOI
https://doi.org/10.3390/jcm12155090
Journal volume & issue
Vol. 12, no. 15
p. 5090

Abstract

Read online

Despite overwhelming epidemiological evidence, the contribution of hypertension (HTN) to heart failure (HF) development has been undermined in current clinical practice. This is because approximately half of HF patients have been labeled as suffering from HF with preserved left ventricular (LV) ejection fraction (EF) (HFpEF), with HTN, obesity, and diabetes mellitus (DM) being considered virtually equally responsible for its development. However, this suggestion is obviously inaccurate, since HTN is by far the most frequent and devastating morbidity present in HFpEF. Further, HF development in obesity or DM is rare in the absence of HTN or coronary artery disease (CAD), whereas HTN often causes HF per se. Finally, unlike HTN, for most major comorbidities present in HFpEF, including anemia, chronic kidney disease, pulmonary disease, DM, atrial fibrillation, sleep apnea, and depression, it is unknown whether they precede HF or result from it. The purpose of this paper is to provide a contemporary overview on hypertensive HF, with a special emphasis on its inflammatory nature and association with autonomic nervous system (ANS) imbalance, since both are of pathophysiologic and therapeutic interest.

Keywords